Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine

The association of antipsychotics is a widespread therapeutic resource in clinical practice. The purpose of the present work was to evaluate the effi cacy and safety of amisulpride augmentation in patients responding at least partially to olanzapine. Methods: In this observational 3-months open-labe...

Descripción completa

Detalles Bibliográficos
Autores: Molina Martín, Juan de Dios, Toledo-Romero, F., López-Rodríguez, E., Amorón Díaz, M., Lerma-Carrillo, I., López-Muñoz, F.
Tipo de recurso: artículo
Fecha de publicación:2011
País:España
Institución:Universidad Camilo José Cela (UCJC)
Repositorio:Depósito Digital e-UCJC
OAI Identifier:oai:repositorio.ucjc.edu:20.500.12020/729
Acceso en línea:http://hdl.handle.net/20.500.12020/729
Access Level:acceso abierto
Palabra clave:Ciencias Biomédicas
Psicología
Amisulpride
Olanzapine
Augmentation
Schizophrenia
Treatment resistance
6113 Psicofarmacología
3209 Farmacología
id ES_c64c2e97929a1f95dd3ea25ff611a6f6
oai_identifier_str oai:repositorio.ucjc.edu:20.500.12020/729
network_acronym_str ES
network_name_str España
repository_id_str
spelling Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapineMolina Martín, Juan de DiosToledo-Romero, F.López-Rodríguez, E.Amorón Díaz, M.Lerma-Carrillo, I.López-Muñoz, F.Ciencias BiomédicasPsicologíaAmisulprideOlanzapineAugmentationSchizophreniaTreatment resistance6113 Psicofarmacología3209 FarmacologíaThe association of antipsychotics is a widespread therapeutic resource in clinical practice. The purpose of the present work was to evaluate the effi cacy and safety of amisulpride augmentation in patients responding at least partially to olanzapine. Methods: In this observational 3-months open-label investigation, we evaluated the eff ectiveness of the addition of amisulpride to 49 subjects, after having scored at least 25 on the brief psychiatric rating scale (BPRS) following olanzapine monotherapy for 6 weeks. Patients were assessed at baseline, 1 and 3 months using the BPRS, the clinical global impression severity of illness (CGI-S) scale and the Udvalg for Kliniske Undersogelser side eff ect rating scale (UKU).2011info:eu-repo/semantics/articlehttp://hdl.handle.net/20.500.12020/729reponame:Depósito Digital e-UCJCinstname:Universidad Camilo José Cela (UCJC)Inglésinfo:eu-repo/semantics/openAccessoai:repositorio.ucjc.edu:20.500.12020/7292026-05-27T07:36:51Z
dc.title.none.fl_str_mv Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
title Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
spellingShingle Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
Molina Martín, Juan de Dios
Ciencias Biomédicas
Psicología
Amisulpride
Olanzapine
Augmentation
Schizophrenia
Treatment resistance
6113 Psicofarmacología
3209 Farmacología
title_short Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
title_full Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
title_fullStr Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
title_full_unstemmed Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
title_sort Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
dc.creator.none.fl_str_mv Molina Martín, Juan de Dios
Toledo-Romero, F.
López-Rodríguez, E.
Amorón Díaz, M.
Lerma-Carrillo, I.
López-Muñoz, F.
author Molina Martín, Juan de Dios
author_facet Molina Martín, Juan de Dios
Toledo-Romero, F.
López-Rodríguez, E.
Amorón Díaz, M.
Lerma-Carrillo, I.
López-Muñoz, F.
author_role author
author2 Toledo-Romero, F.
López-Rodríguez, E.
Amorón Díaz, M.
Lerma-Carrillo, I.
López-Muñoz, F.
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Ciencias Biomédicas
Psicología
Amisulpride
Olanzapine
Augmentation
Schizophrenia
Treatment resistance
6113 Psicofarmacología
3209 Farmacología
topic Ciencias Biomédicas
Psicología
Amisulpride
Olanzapine
Augmentation
Schizophrenia
Treatment resistance
6113 Psicofarmacología
3209 Farmacología
description The association of antipsychotics is a widespread therapeutic resource in clinical practice. The purpose of the present work was to evaluate the effi cacy and safety of amisulpride augmentation in patients responding at least partially to olanzapine. Methods: In this observational 3-months open-label investigation, we evaluated the eff ectiveness of the addition of amisulpride to 49 subjects, after having scored at least 25 on the brief psychiatric rating scale (BPRS) following olanzapine monotherapy for 6 weeks. Patients were assessed at baseline, 1 and 3 months using the BPRS, the clinical global impression severity of illness (CGI-S) scale and the Udvalg for Kliniske Undersogelser side eff ect rating scale (UKU).
publishDate 2011
dc.date.none.fl_str_mv 2011
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12020/729
url http://hdl.handle.net/20.500.12020/729
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Depósito Digital e-UCJC
instname:Universidad Camilo José Cela (UCJC)
instname_str Universidad Camilo José Cela (UCJC)
reponame_str Depósito Digital e-UCJC
collection Depósito Digital e-UCJC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419061659566080
score 15.301603

Similares en LA Referencia